Literature DB >> 17127409

Cdt1 and geminin: role during cell cycle progression and DNA damage in higher eukaryotes.

Shusuke Tada1.   

Abstract

DNA replication in eukaryotic cells must be strictly regulated to ensure that the entire genome is duplicated only once in each cell cycle. For this purpose, the initiation of DNA replication is controlled by the "licensing" reaction, which is established by the formation of a pre-replicative complex (pre-RC) with the sequential assembly of the origin recognition complex (ORC), Cdc6, Cdt1 and Mcm2-7 onto origin regions. Among these, Cdt1 is likely the most important target for regulating licensing in higher eukaryotic cells, since illegitimate accumulation of Cdt1 causes multiple rounds of DNA replication without an intervening mitosis. Cdt1 is regulated over the course of the cell cycle mainly by the controlled expression of an inhibitor protein, geminin, and the level of Cdt1 periodically fluctuates due to ubiquitination and proteolysis. While the expression of geminin from S phase to metaphase of mitosis prevents licensing, Cdt1 accumulates from M to G1 phases and is degraded at the onset of S phase. Furthermore, Cdt1 is also proteolyzed in G1 phase in response to DNA damage, presumably providing a new checkpoint control.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17127409     DOI: 10.2741/2175

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  15 in total

1.  Complex cell cycle abnormalities caused by human T-lymphotropic virus type 1 Tax.

Authors:  Liangpeng Yang; Naoe Kotomura; Yik-Khuan Ho; Huijun Zhi; Sandra Bixler; Michael J Schell; Chou-Zen Giam
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

2.  Orc2 protects ORCA from ubiquitin-mediated degradation.

Authors:  Zhen Shen; Supriya G Prasanth
Journal:  Cell Cycle       Date:  2012-08-30       Impact factor: 4.534

3.  A WD-repeat protein stabilizes ORC binding to chromatin.

Authors:  Zhen Shen; Kizhakke M Sathyan; Yijie Geng; Ruiping Zheng; Arindam Chakraborty; Brian Freeman; Fei Wang; Kannanganattu V Prasanth; Supriya G Prasanth
Journal:  Mol Cell       Date:  2010-10-08       Impact factor: 17.970

4.  Rapid intracellular competition between hepatitis C viral genomes as a result of mitosis.

Authors:  Brian Webster; Silke Wissing; Eva Herker; Melanie Ott; Warner C Greene
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

5.  Endocycling cells do not apoptose in response to DNA rereplication genotoxic stress.

Authors:  Sonam Mehrotra; Shahina B Maqbool; Alexis Kolpakas; Katherine Murnen; Brian R Calvi
Journal:  Genes Dev       Date:  2008-11-15       Impact factor: 11.361

6.  Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase.

Authors:  Halfdan Beck; Viola Nähse; Marie Sofie Yoo Larsen; Petra Groth; Trevor Clancy; Michael Lees; Mette Jørgensen; Thomas Helleday; Randi G Syljuåsen; Claus Storgaard Sørensen
Journal:  J Cell Biol       Date:  2010-03-01       Impact factor: 10.539

7.  Human cytomegalovirus miR-US5-1 inhibits viral replication by targeting Geminin mRNA.

Authors:  Shujuan Jiang; Yujing Huang; Ying Qi; Rong He; Zhongyang Liu; Yanping Ma; Xin Guo; Yaozhong Shao; Zhengrong Sun; Qiang Ruan
Journal:  Virol Sin       Date:  2017-10-31       Impact factor: 4.327

8.  Selective killing of cancer cells by suppression of geminin activity.

Authors:  Wenge Zhu; Melvin L Depamphilis
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

9.  Identification of ORC1/CDC6-interacting factors in Trypanosoma brucei reveals critical features of origin recognition complex architecture.

Authors:  Calvin Tiengwe; Lucio Marcello; Helen Farr; Catarina Gadelha; Richard Burchmore; J David Barry; Stephen D Bell; Richard McCulloch
Journal:  PLoS One       Date:  2012-03-08       Impact factor: 3.240

10.  Molecular mechanisms of DNA replication checkpoint activation.

Authors:  Bénédicte Recolin; Siem van der Laan; Nikolay Tsanov; Domenico Maiorano
Journal:  Genes (Basel)       Date:  2014-03-06       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.